RETATRUTIDE KITS

Description

Retatrutide

Retatrutide is a synthetic investigational peptide studied for its activity at three receptor systems: the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR). It is therefore more accurately described as a triple-receptor agonist, rather than simply “GLP-1R.”

Researchers study retatrutide in controlled laboratory and preclinical environments to better understand multi-receptor signaling, peptide–receptor interactions, and metabolic pathway biology.

Research Applications

• Multi-receptor research models
• Peptide–receptor interaction studies
• Cellular signaling research
• Endocrine-system investigation
• Metabolic-pathway research
• Experimental peptide analysis

Scientific Background

Retatrutide, also identified in scientific literature as LY3437943, has generated research interest because a single peptide demonstrates agonist activity at the GIP, GLP-1, and glucagon receptors. Ongoing research examines its biochemical characteristics, receptor-signaling activity, and molecular interactions in experimental and clinical-research settings.

Specifications

Research Use Only

This product is supplied exclusively for laboratory research and analytical purposes. It is intended only for use by qualified professionals in controlled research environments.

Not for human or animal consumption. Not for clinical, diagnostic, preventive, or therapeutic use. Not intended for compounding, dispensing, or administration.